Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis

Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.

Authors

Harsh Golwala¹, Navkaranbir Singh Bajaj¹, Garima Arora¹, Pankaj Arora²

Affiliations

¹ From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.).
² From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (G.A., P.A.). [email protected].

No abstract available

Keywords: arrhythmias, cardiac; cardiomyopathies; defibrillators, implantable.

Publication types

Letter
Meta-Analysis
Research Support, Non-U.S. Gov't

MeSH terms

Cardiomyopathies / therapy*
Cause of Death
Defibrillators, Implantable*
Electric Countershock*
Humans
Mortality
Primary Prevention
Randomized Controlled Trials as Topic
Treatment Outcome

Grants and funding

T32 HL094301/HL/NHLBI NIH HHS/United States